| # | Drug | Count |
|---|---|---|
| 0 | LAMOTRIGINE | 30 |
| 1 | LEVETIRACETAM | 30 |
| 2 | LEVETIRACETAM IN SODIUM CHLORIDE | 25 |
| 3 | LEVETIRACETAM INJECTION | 25 |
| 4 | LEVETIRACETAM ORAL | 25 |
| 5 | ADALIMUMAB | 22 |
| 6 | LAMOTIRIGINE | 21 |
| 7 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 21 |
| 8 | LAMOTRIGINE EXTENDED-RELEASE | 21 |
| 9 | METHOTREXATE SODIUM | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 1 | 0.0065 |
| 1 | MITOTANE | 9 | 0.0049 |
| 2 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 1 | 0.0029 |
| 3 | PERAMPANEL | 16 | 0.0021 |
| 4 | CLINDAMYCIN PHOSPHATE | 5 | 0.0009 |
| 5 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 6 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 7 | SUZETRIGINE | 1 | 0.0006 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 5 | 0.0006 |
| 9 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Mood Stabilizer [EPC] | 47 |
| 1 | Anti-epileptic Agent [EPC] | 40 |
| 2 | Corticosteroid [EPC] | 35 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 4 | Azole Antifungal [EPC] | 18 |
| 5 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 16 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| 7 | Vitamin C [EPC] | 15 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 9 | Platinum-based Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 16 | 0.0021 |
| 1 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 2 | Melatonin Receptor Agonist [EPC] | 3 | 0.0002 |
| 3 | Mood Stabilizer [EPC] | 47 | 0.0002 |
| 4 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 5 | Anti-epileptic Agent [EPC] | 40 | 0.0002 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 7 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 8 | Rifamycin Antibacterial [EPC] | 5 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |